Company: IMCR
Filing Date: 2025-03-24
Form Type: PRE 14A
Source: 0001140361-25-010035
Chunk: 116

Company: Immunocore Holdings plc
Filing Date: 2025-03-24
Form: PRE 14A
Chunk 116
---
2021              |     | 28 January 2021     |     | —                   |
| Professor Sir Peter Ratcliffe |     | February 2021              |     | 22 January 2021     |     | —                   |
| Travis Coy                    |     | February 2021              |     | 22 January 2021     |     | 1 January 2025      |
| Siddharth Kaul                |     | May 2022                   |     | 8 June 2022         |     | —                   |
| Ranjeev Krishana              |     | May 2024                   |     | 28 May 2024         |     |                     |

Directors’ letters of appointment are available for inspection at the Company’s registered office during normal business hours and will be available for inspection at the AGM. While engaged by the Company, Non-Executive Directors engaged in any other employment, occupation, or business enterprise will keep the Group’s Nominations Committee informed of any changes to their status or any conflicts that emerge. The Board recognises the potential for a Non-Executive to be involved in such engagements, as well as volunteering work, or service on another board of directors, so long as such activities do not interfere in any material way or conflict with the performance of the Non-Executive Director’s duties and responsibilities. Statement of Consideration of Employment Conditions Elsewhere in the Group The Committee is regularly updated throughout the year on pay and conditions applying to Group employees. Where significant changes are proposed to employment conditions elsewhere in the Group, these are highlighted for the attention of the Committee. Although the Committee does not consult with employees directly, it is apprised of any decisions relating to pay for the broader workforce and will consider pay conditions throughout the Group when making decisions on Executive Directors’ remuneration. Statement of Consideration of Shareholder Views The Board is committed to an open dialogue with shareholders. Following each AGM, the Board will look to receive any feedback and guidance from shareholders, as well as any additional feedback and guidance from time to time throughout the year. This feedback will be incorporated into the Committee’s discussions as it develops the Company’s remuneration framework and practices for the following year. Assisted by its independent adviser, the Committee and the Board will also actively monitor developments in the expectations of institutional investors and their representative bodies. Annual Report of Remuneration Remuneration Committee The compensation of the Executive Director and the Chair is determined by the Board. The members of the Committee during